Payden & Rygel’s Novartis NVS Stock Holding History

Payden & Rygel’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-876	Closed	-$83K	–	145
2020 Q4	$83K	Hold	876	–	–	﹤0.01%	119
2020 Q3	$76K	Hold	876	–	–	﹤0.01%	109
2020 Q2	$77K	Hold	876	–	–	﹤0.01%	100
2020 Q1	$72K	Hold	876	–	–	0.01%	100
2019 Q4	$83K	Hold	876	–	–	0.01%	106
2019 Q3	$76K	Hold	876	–	–	0.01%	104
2019 Q2	$80K	Sell	876 -102	-10%	-$8.63K	0.01%	102
2019 Q1	$84K	Hold	978	–	–	0.01%	100
2018 Q4	$75K	Hold	978	–	–	0.01%	102
2018 Q3	$75K	Hold	978	–	–	0.01%	101
2018 Q2	$66K	Hold	978	–	–	0.01%	101
2018 Q1	$71K	Hold	978	–	–	0.01%	101
2017 Q4	$74K	Hold	978	–	–	0.01%	100
2017 Q3	$75K	Hold	978	–	–	0.01%	100
2017 Q2	$73K	Hold	978	–	–	0.01%	94
2017 Q1	$65K	Hold	978	–	–	0.01%	97
2016 Q4	$64K	Hold	978	–	–	0.01%	95
2016 Q3	$69K	Hold	978	–	–	0.01%	89
2016 Q2	$72K	Hold	978	–	–	0.01%	87
2016 Q1	$63K	Sell	978 -138	-12%	-$9.39K	0.01%	95
2015 Q4	$86K	Buy	1,116 +138	+14%	+$11K	0.01%	96
2015 Q3	$81K	Hold	978	–	–	0.01%	95
2015 Q2	$86K	Hold	978	–	–	0.01%	98
2015 Q1	$86K	Hold	978	–	–	0.01%	102
2014 Q4	$81K	Hold	978	–	–	0.02%	96
2014 Q3	$82K	Sell	978 -669	-41%	-$54.1K	0.02%	101
2014 Q2	$134K	Hold	1,647	–	–	0.03%	88
2014 Q1	$125K	Hold	1,647	–	–	0.05%	81
2013 Q4	$119K	Hold	1,647	–	–	0.04%	110
2013 Q3	$113K	Hold	1,647	–	–	0.04%	107
2013 Q2	$104K	Buy	+1,647	New	+$107K	0.04%	107

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Payden & Rygel's NVS Position: Q1 2021 in Review

Payden & Rygel sold out of Novartis (NVS) in Q1 2021, closing a stake of 876 shares — an estimated $83K sold.

Payden & Rygel first reported a position in NVS in Q2 2013 and held it in 31 quarters. The position peaked at $134K in Q2 2014. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2021.

Payden & Rygel reported no remaining Novartis position as of Q1 2021 after selling out during the quarter.
Payden & Rygel sold 876 Novartis shares in Q1 2021, an estimated $83K.
Payden & Rygel first reported a position in Novartis in Q2 2013 and held it in 31 quarters.
Payden & Rygel's Novartis position peaked at $134K in Q2 2014.
1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2021.

Based on Payden & Rygel's 13F filing for Q1 2021, filed 13 May 2021.